Evidence map›Paper›PMID 39742392›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Nitric Oxide-Releasing Nanoscale Metal-Organic Layer Overcomes Hypoxia and Reactive Oxygen Species Diffusion Barriers to Enhance Cancer Radiotherapy.

Yuxuan Xiong, Jinhong Li, Xiaomin Jiang, Wenyao Zhen, Xin Ma, Wenbin Lin

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Radiotherapy meets anticancer metallodrugs.Medical review (2021) · 2026
    Article
  4. Multifunctional CuFrontiers in chemistry · 2026
    Review
  5. Hollow MnOInternational journal of nanomedicine · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yuxuan XiongDepartment of Chemistry, The University of Chicago, Chicago, IL, 60637, USA.
Jinhong LiDepartment of Chemistry, The University of Chicago, Chicago, IL, 60637, USA.
Xiaomin JiangDepartment of Chemistry, The University of Chicago, Chicago, IL, 60637, USA.
Wenyao ZhenDepartment of Chemistry, The University of Chicago, Chicago, IL, 60637, USA.
Xin MaDepartment of Chemistry, The University of Chicago, Chicago, IL, 60637, USA.
Wenbin LinDepartment of Chemistry, The University of Chicago, Chicago, IL, 60637, USA.ORCID https://orcid.org/0000-0001-7035-7759

Funding

Nanoscale Metal-Organic Frameworks Enable Radiotherapy-Radiodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Generate Tumor Vaccines and Potentiate Immunotherapy of Head and Neck CancersR01CA253655 · NCI · UNIVERSITY OF CHICAGO · PI LIN, WENBIN, WEICHSELBAUM, RALPH R · 2020 to 2024
$2.5M
NCI NIH HHS R01 CA253655NIH HHS 1R01CA253655
6 · The paper itself

Abstract

Hafnium (Hf)-based nanoscale metal-organic layers (MOLs) enhance radiotherapeutic effects of tissue-penetrating X-rays via a unique radiotherapy-radiodynamic therapy (RT-RDT) process through efficient generation of hydroxy radical (RT) and singlet oxygen (RDT). However, their radiotherapeutic efficacy is limited by hypoxia in deep-seated tumors and short half-lives of reactive oxygen species (ROS). Herein the conjugation of a nitric oxide (NO) donor, S-nitroso-N-acetyl-DL-penicillamine (SNAP), to the Hf

Indexed as

Metal-Organic FrameworksNeoplasmsNitric OxideRadiotherapyReactive Oxygen SpeciesAnimalsCell Line, TumorFemaleHumansMiceS-Nitroso-N-AcetylpenicillamineMetal-Organic FrameworksNitric OxideReactive Oxygen SpeciesS-Nitroso-N-Acetylpenicillaminehypoxiametal‐organic layersnitric oxideradiotherapyreactive oxygen species

Identifiers

PMID39742392
PMCPMC11848595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.